1222301

Sucampo Pharma, LLC — FEI 3009036781

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 27, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Kobe (Japan)